237 related articles for article (PubMed ID: 30849393)
1. ADAR1: A New Target for Immuno-oncology Therapy.
Bhate A; Sun T; Li JB
Mol Cell; 2019 Mar; 73(5):866-868. PubMed ID: 30849393
[TBL] [Abstract][Full Text] [Related]
2. Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown.
Chung H; Calis JJA; Wu X; Sun T; Yu Y; Sarbanes SL; Dao Thi VL; Shilvock AR; Hoffmann HH; Rosenberg BR; Rice CM
Cell; 2018 Feb; 172(4):811-824.e14. PubMed ID: 29395325
[TBL] [Abstract][Full Text] [Related]
3. Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade.
Ishizuka JJ; Manguso RT; Cheruiyot CK; Bi K; Panda A; Iracheta-Vellve A; Miller BC; Du PP; Yates KB; Dubrot J; Buchumenski I; Comstock DE; Brown FD; Ayer A; Kohnle IC; Pope HW; Zimmer MD; Sen DR; Lane-Reticker SK; Robitschek EJ; Griffin GK; Collins NB; Long AH; Doench JG; Kozono D; Levanon EY; Haining WN
Nature; 2019 Jan; 565(7737):43-48. PubMed ID: 30559380
[TBL] [Abstract][Full Text] [Related]
4. ADAR1 interaction with Z-RNA promotes editing of endogenous double-stranded RNA and prevents MDA5-dependent immune activation.
de Reuver R; Dierick E; Wiernicki B; Staes K; Seys L; De Meester E; Muyldermans T; Botzki A; Lambrecht BN; Van Nieuwerburgh F; Vandenabeele P; Maelfait J
Cell Rep; 2021 Aug; 36(6):109500. PubMed ID: 34380029
[TBL] [Abstract][Full Text] [Related]
5. The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways.
Nakahama T; Kawahara Y
Int Immunol; 2023 Mar; 35(3):123-133. PubMed ID: 36469491
[TBL] [Abstract][Full Text] [Related]
6. ADAR1, inosine and the immune sensing system: distinguishing self from non-self.
Liddicoat BJ; Chalk AM; Walkley CR
Wiley Interdiscip Rev RNA; 2016; 7(2):157-72. PubMed ID: 26692549
[TBL] [Abstract][Full Text] [Related]
7. RNA editing and immune control: from mechanism to therapy.
Hu SB; Li JB
Curr Opin Genet Dev; 2024 Jun; 86():102195. PubMed ID: 38643591
[TBL] [Abstract][Full Text] [Related]
8. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.
Mannion NM; Greenwood SM; Young R; Cox S; Brindle J; Read D; Nellåker C; Vesely C; Ponting CP; McLaughlin PJ; Jantsch MF; Dorin J; Adams IR; Scadden AD; Ohman M; Keegan LP; O'Connell MA
Cell Rep; 2014 Nov; 9(4):1482-94. PubMed ID: 25456137
[TBL] [Abstract][Full Text] [Related]
9. Detection of A-to-I RNA Editing in SARS-COV-2.
Picardi E; Mansi L; Pesole G
Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052382
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the adenosine deaminase ADAR1 that prevent endogenous Z-RNA binding induce Aicardi-Goutières-syndrome-like encephalopathy.
Nakahama T; Kato Y; Shibuya T; Inoue M; Kim JI; Vongpipatana T; Todo H; Xing Y; Kawahara Y
Immunity; 2021 Sep; 54(9):1976-1988.e7. PubMed ID: 34525338
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency.
Mehdipour P; Marhon SA; Ettayebi I; Chakravarthy A; Hosseini A; Wang Y; de Castro FA; Loo Yau H; Ishak C; Abelson S; O'Brien CA; De Carvalho DD
Nature; 2020 Dec; 588(7836):169-173. PubMed ID: 33087935
[TBL] [Abstract][Full Text] [Related]
12. The RNA-Specific Adenosine Deaminase ADAR1 Inhibits Human Protein Kinase R Activation.
Wang TT; Li ZG; Wang Q
Viral Immunol; 2018 Sep; 31(7):537-538. PubMed ID: 29883277
[No Abstract] [Full Text] [Related]
13. The Other Face of an Editor: ADAR1 Functions in Editing-Independent Ways.
Licht K; Jantsch MF
Bioessays; 2017 Nov; 39(11):. PubMed ID: 28960389
[TBL] [Abstract][Full Text] [Related]
14. ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses.
Herzner AM; Khan Z; Van Nostrand EL; Chan S; Cuellar T; Chen R; Pechuan-Jorge X; Komuves L; Solon M; Modrusan Z; Haley B; Yeo GW; Behrens TW; Albert ML
J Exp Med; 2021 Sep; 218(9):. PubMed ID: 34297039
[TBL] [Abstract][Full Text] [Related]
15. Virus-specific editing identification approach reveals the landscape of A-to-I editing and its impacts on SARS-CoV-2 characteristics and evolution.
Song Y; He X; Yang W; Wu Y; Cui J; Tang T; Zhang R
Nucleic Acids Res; 2022 Mar; 50(5):2509-2521. PubMed ID: 35234938
[TBL] [Abstract][Full Text] [Related]
16. What do editors do? Understanding the physiological functions of A-to-I RNA editing by adenosine deaminase acting on RNAs.
Heraud-Farlow JE; Walkley CR
Open Biol; 2020 Jul; 10(7):200085. PubMed ID: 32603639
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the Biological Significance of ADAR1-Z-RNA Interactions.
Nakahama T; Kawahara Y
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768866
[TBL] [Abstract][Full Text] [Related]
18. Protein recoding by ADAR1-mediated RNA editing is not essential for normal development and homeostasis.
Heraud-Farlow JE; Chalk AM; Linder SE; Li Q; Taylor S; White JM; Pang L; Liddicoat BJ; Gupte A; Li JB; Walkley CR
Genome Biol; 2017 Sep; 18(1):166. PubMed ID: 28874170
[TBL] [Abstract][Full Text] [Related]
19. Distinct in vivo roles for double-stranded RNA-binding domains of the Xenopus RNA-editing enzyme ADAR1 in chromosomal targeting.
Doyle M; Jantsch MF
J Cell Biol; 2003 Apr; 161(2):309-19. PubMed ID: 12719472
[TBL] [Abstract][Full Text] [Related]
20. The role of RNA editing by ADAR1 in prevention of innate immune sensing of self-RNA.
Heraud-Farlow JE; Walkley CR
J Mol Med (Berl); 2016 Oct; 94(10):1095-1102. PubMed ID: 27044320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
